- Home
- CBT vs CRNX Comparison
CBT vs CRNX Comparison
Compare CBT & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBT
- CRNX
- Stock Information
- Founded
- CBT 2019
- CRNX 2008
- Country
- CBT United States
- CRNX United States
- Employees
- CBT N/A
- CRNX N/A
- Industry
- CBT Major Chemicals
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- CBT Industrials
- CRNX Health Care
- Exchange
- CBT Nasdaq
- CRNX Nasdaq
- Market Cap
- CBT 4.0B
- CRNX 2.8B
- IPO Year
- CBT N/A
- CRNX 2018
- Fundamental
- Price
- CBT $78.64
- CRNX $31.75
- Analyst Decision
- CBT Hold
- CRNX Strong Buy
- Analyst Count
- CBT 3
- CRNX 8
- Target Price
- CBT $92.67
- CRNX $74.86
- AVG Volume (30 Days)
- CBT 380.5K
- CRNX 725.8K
- Earning Date
- CBT 08-04-2025
- CRNX 08-07-2025
- Dividend Yield
- CBT 2.29%
- CRNX N/A
- EPS Growth
- CBT N/A
- CRNX N/A
- EPS
- CBT 7.72
- CRNX N/A
- Revenue
- CBT $3,908,000,000.00
- CRNX $760,000.00
- Revenue This Year
- CBT N/A
- CRNX $402.02
- Revenue Next Year
- CBT $3.55
- CRNX $771.03
- P/E Ratio
- CBT $10.16
- CRNX N/A
- Revenue Growth
- CBT N/A
- CRNX N/A
- 52 Week Low
- CBT $71.64
- CRNX $24.10
- 52 Week High
- CBT $117.46
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- CBT 56.99
- CRNX 57.94
- Support Level
- CBT $76.17
- CRNX $28.98
- Resistance Level
- CBT $79.61
- CRNX $32.49
- Average True Range (ATR)
- CBT 1.75
- CRNX 1.24
- MACD
- CBT 0.35
- CRNX 0.30
- Stochastic Oscillator
- CBT 81.81
- CRNX 90.54
About CBT Cabot Corporation
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.